Sensorion Presents Three Posters At The 55th Inner Ear Biology Workshop
September 06, 2018 01:30 ET
|
Sensorion
MONTPELLIER, France, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today presented three posters at the...
Sensorion Announces Three Poster Presentations At The 55th Inner Ear Biology Workshop
September 03, 2018 01:30 ET
|
Sensorion
MONTPELLIER, France, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present three posters at the...
Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss
August 20, 2018 01:30 ET
|
Sensorion
Sensorion’s 2nd European Voluntary Harmonization Procedure Application Approval International Multicenter Phase 2 with SENS-401 for Treating Sudden Sensorineuronal Hearing Loss in Adults to Start ...
Sensorion Initiates Safety Study of Seliforant Versus Meclizine In Evoked Vestibular Imbalance
July 24, 2018 01:30 ET
|
Sensorion
Safety and pharmacodynamic effects of seliforant compared to meclizine MONTPELLIER, France, July 24, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the...
Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models
June 29, 2018 01:30 ET
|
Sensorion
MONTPELLIER, France, June 29, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, presented data showing that its...
Sensorion Announces Oral Presentation at the 15th International Conference on Cochlear Implants and Other Implantable Auditory Technologies (Ci2018)
June 06, 2018 01:30 ET
|
Sensorion
The company will present preclinical data on the otoprotective capacity of SENS-401 which may benefit cochlear implant patients MONTPELLIER, France, June 06, 2018 (GLOBE NEWSWIRE) -- Sensorion...
Sensorion’s Chair of Scientific Advisory Board, Prof. Christine Petit, Awarded 2018 Kavli Prize in Neuroscience
June 04, 2018 11:35 ET
|
Sensorion
Christine Petit, A. James Hudspeth, and Robert Fettiplace recognized for their pioneering work on the molecular and neural mechanisms of hearing. MONTPELLIER, France, June 04, 2018 (GLOBE NEWSWIRE)...
Sensorion to Present at the 2018 BIO International Convention
June 01, 2018 11:35 ET
|
Sensorion
MONTPELLIER, France, June 01, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present at the 25th BIO...
Sensorion Appoints Professor Christine Petit, MD, PhD as Chair of its Scientific Advisory Board
May 22, 2018 01:30 ET
|
Sensorion
Internationally-renowned geneticist and neurobiologist with decades of hearing research leadership to head Sensorion’s Scientific Advisory Board MONTPELLIER, France, May 22, 2018 (GLOBE NEWSWIRE)...
World Health Organization Grants Name ‘Seliforant’ to Sensorion’s SENS-111 Treatment
May 03, 2018 01:30 ET
|
Sensorion
Seliforant (formerly SENS-111) is a first-in-class histamine H4 receptor antagonist candidate selected for the treatment of vertigo of vestibular origin, in development to treat acute unilateral...